What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Enzyme
- Gene
The scientist’s investigation covers issues in Immunology, Lung injury, Inflammation, Sepsis and Lung.
As part of his studies on Immunology, Peter A. Ward often connects relevant subjects like Chemotaxis.
Peter A. Ward has included themes like Immune complex, Pathology, Vascular permeability, Bronchoalveolar lavage and Myeloperoxidase in his Lung injury study.
His work carried out in the field of Inflammation brings together such families of science as Cancer research, Phagocyte and Superoxide.
His Sepsis research includes elements of Receptor, Blockade, Innate immune system, Intensive care medicine and C5a receptor.
His work deals with themes such as Endocrinology and Superoxide dismutase, which intersect with Lung.
His most cited work include:
- Role of oxygen-derived free radicals and metabolites in leukocyte-dependent inflammatory reactions. (1106 citations)
- Immunodesign of experimental sepsis by cecal ligation and puncture. (1000 citations)
- Harmful molecular mechanisms in sepsis (871 citations)
What are the main themes of his work throughout his whole career to date?
Immunology, Lung injury, Inflammation, Sepsis and Lung are his primary areas of study.
His Immunology study is mostly concerned with Complement system, Immune system, Immune complex, Chemokine and Innate immune system.
His work in Lung injury addresses subjects such as Pharmacology, which are connected to disciplines such as Biochemistry.
His Inflammation research is multidisciplinary, incorporating perspectives in Cytokine and In vivo.
In his work, Endocrinology is strongly intertwined with Receptor, which is a subfield of Sepsis.
His Lung study deals with Pathology intersecting with Ischemia.
He most often published in these fields:
- Immunology (46.87%)
- Lung injury (25.20%)
- Inflammation (21.25%)
What were the highlights of his more recent work (between 2008-2020)?
- Immunology (46.87%)
- Sepsis (16.89%)
- Inflammation (21.25%)
In recent papers he was focusing on the following fields of study:
Peter A. Ward spends much of his time researching Immunology, Sepsis, Inflammation, Complement system and Lung injury.
His Immunology study frequently draws parallels with other fields, such as Extracellular.
His study in Sepsis is interdisciplinary in nature, drawing from both Tumor necrosis factor alpha, Immunosuppression, Immunity, Intensive care medicine and Antibody.
He interconnects Integrin alpha M, Disease and Cytokine in the investigation of issues within Inflammation.
He focuses mostly in the field of Complement system, narrowing it down to topics relating to Receptor and, in certain cases, Endocrinology, Cell biology and Signal transduction.
Peter A. Ward works mostly in the field of Lung injury, limiting it down to topics relating to Bronchoalveolar lavage and, in certain cases, Pathology.
Between 2008 and 2020, his most popular works were:
- Immunodesign of experimental sepsis by cecal ligation and puncture. (1000 citations)
- The complement system. (555 citations)
- Sepsis-induced immune dysfunction: can immune therapies reduce mortality? (250 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Enzyme
- Gene
His scientific interests lie mostly in Immunology, Inflammation, Lung injury, Sepsis and Complement system.
His work on Immune system, Innate immune system and Anaphylatoxin as part of general Immunology research is often related to Popular press, thus linking different fields of science.
His Inflammation study incorporates themes from Reperfusion injury, Disease and In vivo.
His study on Lung injury is covered under Lung.
His Sepsis research includes themes of Complement C5a, Pathophysiology and Type 2 Diabetes Mellitus.
His study looks at the intersection of Complement system and topics like Receptor with Signal transduction, Cell biology and Endocrinology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
